1. OC 8721 WANECAM II – a clinical trial programme to assess safety, efficacy and transmission-blocking properties of a new antimalarial KAF156 (ganaplacide) in uncomplicated malaria in west and central africa. (24th April 2019) Authors: Djimde, Abdoulaye; Grobusch, Martin P; Zoleko Manego, Rella; Mombo-Ngoma, Ghyslain; Picot, Stephane; Sagara, Issaka; Sutherland, Colin; Kone, Aminatou; Doumbo, Ogobara K; Pedro Gil, Jose; Björkman, Anders; Borrmann, Steffen; Soulama, Issiaka; Fofana, Bakary; Duparc, Stephan; Dicko, Alassane; Hugh... Journal: BMJ global health Issue: Volume 4(2019)Supplement 3 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗